In situハイブリダイゼーション(ISH)の世界市場2020-2024

◆英語タイトル:Global In Situ Hybridization (ISH) Market 2020-2024
◆商品コード:TNV20FB062
◆発行会社(リサーチ会社):Technavio
◆発行日:2020年1月16日
◆ページ数:100
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥275,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥330,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Technavio社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

「In situハイブリダイゼーション(ISH)の世界市場2020-2024」は、In situハイブリダイゼーション(ISH)について市場概要、市場規模、技術別(FISH、CISH)分析、エンドユーザー別(分子診断研究所、製薬およびバイオテクノロジー企業、その他)分析、顧客状況、地域状況、市場の要因・課題、市場トレンド、企業状況、企業分析などを総合的にまとめて調査・分析したものです。
・エグゼクティブサマリー
・レポート範囲
・市場概要
・市場規模
・ファイブフォース分析
・In situハイブリダイゼーション(ISH)の世界市場:技術別(FISH、CISH)
・In situハイブリダイゼーション(ISH)の世界市場:エンドユーザー別(分子診断研究所、製薬およびバイオテクノロジー企業、その他)
・顧客状況
・地域状況
・決定フレームワーク
・市場の要因・課題
・市場トレンド
・企業状況
・企業分析
【レポートの概要】

Global In Situ Hybridization (ISH) Market 2020-2024
Technavio has been monitoring the global in situ hybridization (ISH) market and it is poised to grow by USD 346.61 mn during 2020-2024, progressing at a CAGR of 7% during the forecast period. Our reports on global in situ hybridization (ISH) market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increasing demand for companion diagnostic tests. In addition, national initiatives across the globe spurring molecular research activities is anticipated to boost the growth of the global in situ hybridization (ISH) market as well.

Market Segmentation

Technavio’s global in situ hybridization (ISH) market is segmented as below:
Technology
• Fish
• Cish

End-User
• Molecular Diagnostic Laboratories
• Pharmaceutical And Biotechnology Companies
• Others

Geographic segmentation
• APAC
• Europe
• MEA
• North America
• South America

Key Trends for global in situ hybridization (ISH) market growth
This study identifies national initiatives across the globe spurring molecular research activities as the prime reasons driving the global in situ hybridization (ISH) market growth during the next few years.

Prominent vendors in global in situ hybridization (ISH) market
We provide a detailed analysis of around 25 vendors operating in the global in situ hybridization (ISH) market, including some of the vendors such as Abbott Laboratories, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Bio-Techne Corp., F. Hoffmann-La Roche Ltd., Merck KGaA, NeoGenomics Inc., PerkinElmer Inc., Qiagen NV and Thermo Fisher Scientific Inc.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors. For further information on this report, please visit -https://www.technavio.com/report/global-in-situ-hybridization-ish-market-industry-analysis

About Technavio
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

【レポートの目次】

01: EXECUTIVE SUMMARY
02: SCOPE OF THE REPORT
1. 2.1 Preface
2. 2.2 Preface
2.3 Currency conversion rates for US$
03: MARKET LANDSCAPE
3. Market ecosystem
4. Market characteristics
5. Market segmentation analysis
04: MARKET SIZING
6. Market definition
7. Market sizing 2019
8. Market size and forecast 2019-2024
05: FIVE FORCES ANALYSIS
9. Bargaining power of buyers
10. Bargaining power of suppliers
11. Threat of new entrants
12. Threat of substitutes
13. Threat of rivalry
14. Market condition
06: MARKET SEGMENTATION BY TECHNOLOGY
15. Market segmentation by technology
16. Comparison by technology
17. FISH – Market size and forecast 2019-2024
18. CISH – Market size and forecast 2019-2024
19. Market opportunity by technology
07: CUSTOMER LANDSCAPE
08: MARKET SEGMENTATION BY END-USER
20. Market segmentation by end-user
21. Comparison by end-user
22. Molecular diagnostic laboratories – Market size and forecast 2019-2024
23. Pharmaceutical and biotechnology companies –
24. Market size and forecast 2019-2024
25. Others – Market size and forecast 2019-2024
26. Market opportunity by end-user
09: GEOGRAPHIC LANDSCAPE
27. Geographic segmentation
28. Geographic comparison
29. North America – Market size and forecast 2019-2024
30. Europe – Market size and forecast 2019-2024
31. APAC – Market size and forecast 2019-2024
32. South America – Market size and forecast 2019-2024
33. MEA – Market size and forecast 2019-2024
34. Key leading countries
35. Market opportunity
10: DECISION FRAMEWORK
11: DRIVERS AND CHALLENGES
36. Market drivers
37. Market challenges
12: MARKET TRENDS
38. Increasing M&A activity in molecular diagnostics market
39. National initiatives across the globe spurring molecular research activities
40. Increasing importance of promotional activities
13: VENDOR LANDSCAPE
41. Overview
42. Landscape disruption
43. Competitive scenario
14: VENDOR ANALYSIS
44. Vendors covered
45. Vendor classification
46. Market positioning of vendors
47. Abbott Laboratories
48. Agilent Technologies Inc.
49. Bio-Rad Laboratories Inc.
50. Bio-Techne Corp.
51. F. Hoffmann-La Roche Ltd.
52. Merck KGaA
53. NeoGenomics Inc.
54. PerkinElmer Inc.
55. Qiagen NV
56. Thermo Fisher Scientific Inc.
15: APPENDIX
57. Research methodology
58. List of abbreviations
59. Definition of market positioning of vendors
16: EXPLORE TECHNAVIO


Exhibit 01: Global life sciences tools and services market
Exhibit 02: Segments of global life sciences tools and services market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Differences between CISH and FISH
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2019
Exhibit 18: Technology – Market share 2019-2024 (%)
Exhibit 19: Comparison by technology
Exhibit 20: FISH – Market size and forecast 2019-2024 ($ millions)
Exhibit 21: FISH – Year-over-year growth 2020-2024 (%)
Exhibit 22: CISH – Market size and forecast 2019-2024 ($ millions)
Exhibit 23: CISH – Year-over-year growth 2020-2024 (%)
Exhibit 24: Market opportunity by technology
Exhibit 25: Customer landscape
Exhibit 26: End-user – Market share 2019-2024 (%)
Exhibit 27: Comparison by end-user
Exhibit 28: Molecular diagnostic laboratories – Market size and forecast 2019-2024 ($ millions)
Exhibit 29: Molecular diagnostic laboratories – Year-over-year growth 2020-2024 (%)
Exhibit 30: Pharmaceutical and biotechnology companies – Market size and forecast 2019-2024 ($ millions)
Exhibit 31: Pharmaceutical and biotechnology companies – Year-over-year growth 2020-2024 (%)
Exhibit 32: Others – Market size and forecast 2019-2024 ($ millions)
Exhibit 33: Others – Year-over-year growth 2020-2024 (%)
Exhibit 34: Market opportunity by end-user
Exhibit 35: Market share by geography 2019-2024 (%)
Exhibit 36: Geographic comparison
Exhibit 37: North America – Market size and forecast 2019-2024 ($ millions)
Exhibit 38: North America – Year-over-year growth 2020-2024 (%)
Exhibit 39: Europe – Market size and forecast 2019-2024 ($ millions)
Exhibit 40: Europe – Year-over-year growth 2020-2024 (%)
Exhibit 41: APAC – Market size and forecast 2019-2024 ($ millions)
Exhibit 42: APAC – Year-over-year growth 2020-2024 (%)
Exhibit 43: South America – Market size and forecast 2019-2024 ($ millions)
Exhibit 44: South America – Year-over-year growth 2020-2024 (%)
Exhibit 45: MEA – Market size and forecast 2019-2024 ($ millions)
Exhibit 46: MEA – Year-over-year growth 2020-2024 (%)
Exhibit 47: Key leading countries
Exhibit 48: Market opportunity
Exhibit 49: List of FDA-approved companion diagnostic tests using ISH
Exhibit 50: Head-to-head comparison between traditional FISH and DMI
Exhibit 51: Impact of drivers and challenges
Exhibit 52: Vendor landscape
Exhibit 53: Landscape disruption
Exhibit 54: Vendors covered
Exhibit 55: Vendor classification
Exhibit 56: Market positioning of vendors
Exhibit 57: Abbott Laboratories – Vendor overview
Exhibit 58: Abbott Laboratories – Business segments
Exhibit 59: Abbott Laboratories – Organizational developments
Exhibit 60: Abbott Laboratories – Geographic focus
Exhibit 61: Abbott Laboratories – Segment focus
Exhibit 62: Abbott Laboratories – Key offerings
Exhibit 63: Agilent Technologies Inc. – Vendor overview
Exhibit 64: Agilent Technologies Inc. – Business segments
Exhibit 65: Agilent Technologies Inc. – Organizational developments
Exhibit 66: Agilent Technologies Inc. – Geographic focus
Exhibit 67: Agilent Technologies Inc. – Segment focus
Exhibit 68: Agilent Technologies Inc. – Key offerings
Exhibit 69: Bio-Rad Laboratories Inc. – Vendor overview
Exhibit 70: Bio-Rad Laboratories Inc. – Business segments
Exhibit 71: Bio-Rad Laboratories Inc. – Organizational developments
Exhibit 72: Bio-Rad Laboratories Inc. – Geographic focus
Exhibit 73: Bio-Rad Laboratories Inc. – Segment focus
Exhibit 74: Bio-Rad Laboratories Inc. – Key offerings
Exhibit 75: Bio-Techne Corp. – Vendor overview
Exhibit 76: Bio-Techne Corp. – Business segments
Exhibit 77: Bio-Techne Corp. – Organizational developments
Exhibit 78: Bio-Techne Corp. – Geographic focus
Exhibit 79: Bio-Techne Corp. – Segment focus
Exhibit 80: Bio-Techne Corp. – Key offerings
Exhibit 81: F. Hoffmann-La Roche Ltd. – Vendor overview
Exhibit 82: F. Hoffmann-La Roche Ltd. – Business segments
Exhibit 83: F. Hoffmann-La Roche Ltd. – Organizational developments
Exhibit 84: F. Hoffmann-La Roche Ltd. – Geographic focus
Exhibit 85: F. Hoffmann-La Roche Ltd. – Segment focus
Exhibit 86: F. Hoffmann-La Roche Ltd. – Key offerings
Exhibit 87: Merck KGaA – Vendor overview
Exhibit 88: Merck KGaA – Business segments
Exhibit 89: Merck KGaA – Organizational developments
Exhibit 90: Merck KGaA – Geographic focus
Exhibit 91: Merck KGaA – Segment focus
Exhibit 92: Merck KGaA – Key offerings
Exhibit 93: NeoGenomics Inc. – Vendor overview
Exhibit 94: NeoGenomics Inc. – Business segments
Exhibit 95: NeoGenomics Inc. – Organizational developments
Exhibit 96: NeoGenomics Inc. – Segment focus
Exhibit 97: NeoGenomics Inc. – Key offerings
Exhibit 98: PerkinElmer Inc. – Vendor overview
Exhibit 99: PerkinElmer Inc. – Business segments
Exhibit 100: PerkinElmer Inc. – Organizational developments
Exhibit 101: PerkinElmer Inc. – Geographic focus
Exhibit 102: PerkinElmer Inc. – Segment focus
Exhibit 103: PerkinElmer Inc. – Key offerings
Exhibit 104: Qiagen NV – Vendor overview
Exhibit 105: Qiagen NV – Business segments
Exhibit 106: Qiagen NV – Organizational developments
Exhibit 107: Qiagen NV – Geographic focus
Exhibit 108: Qiagen NV – Segment focus
Exhibit 109: Qiagen NV – Key offerings
Exhibit 110: Thermo Fisher Scientific Inc. – Vendor overview
Exhibit 111: Thermo Fisher Scientific Inc. – Business segments
Exhibit 112: Thermo Fisher Scientific Inc. – Organizational developments
Exhibit 113: Thermo Fisher Scientific Inc. – Geographic focus
Exhibit 114: Thermo Fisher Scientific Inc. – Segment focus
Exhibit 115: Thermo Fisher Scientific Inc. – Key offerings
Exhibit 116: Validation techniques employed for market sizing
Exhibit 117: Definition of market positioning of vendors



【掲載企業】

Abbott Laboratories
Agilent Technologies Inc.
Bio-Rad Laboratories Inc.
Bio-Techne Corp.
F. Hoffmann-La Roche Ltd.
Merck KGaA
NeoGenomics Inc.
PerkinElmer Inc.
Qiagen NV
Thermo Fisher Scientific Inc.

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[In situハイブリダイゼーション(ISH)の世界市場2020-2024]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆